Close Menu

OCI

NEW YORK (GenomeWeb News) – Canada's Princess Margaret Cancer Foundation said today that it will use a new C$50 million (US$50.3 million) private donation to fund a research effort that will use genomics, molecular imaging, and tumor biology studies to develop personalized cancer medicine innovat

This story has been updated to include additional information from a US survey on people's attitudes about cost of genetic testing. Originally published June 4.

Two Ontario cancer institutes will use the support to seek biomarkers for colorectal cancer.

Founded in 2000 on technology developed at the Ontario Cancer Institute and University of Toronto, Molecular Templates had difficulty securing add-on funding in its home country following a $1.5 million investment earlier this decade.

Australia's National Health and Medical Research Council has awarded the University of Queensland about US$19.3 million to support it's cancer genome sequencing project aimed at characterizing pancreatic and ovarian cancers.

A team of Ontario researchers has identified a six-gene signature that can help predict non-small cell lung cancer outcomes — and uncovered evidence that there may be thousands of alternative prognostic signatures for the disease.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.